Bryan James to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Bryan James has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.075
-
The views of Alzheimer disease patients and their study partners on proxy consent for clinical trial enrollment. Am J Geriatr Psychiatry. 2008 Mar; 16(3):240-7.
Score: 0.075
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.